Application Sponsors
Marketing Status
Application Products
001 | OINTMENT;TOPICAL | 2% | 1 | AKNE-MYCIN | ERYTHROMYCIN |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1985-01-10 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1995-07-14 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1995-07-14 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1997-09-22 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 2001-02-28 | STANDARD |
Submissions Property Types
SUPPL | 2 | Null | 0 |
SUPPL | 3 | Null | 0 |
SUPPL | 4 | Null | 0 |
SUPPL | 5 | Null | 0 |
CDER Filings
BAUSCH
cder:Array
(
[0] => Array
(
[ApplNo] => 50584
[companyName] => BAUSCH
[docInserts] => ["",""]
[products] => [{"drugName":"AKNE-MYCIN","activeIngredients":"ERYTHROMYCIN","strength":"2%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"AKNE-MYCIN","submission":"ERYTHROMYCIN","actionType":"2%","submissionClassification":"OINTMENT;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)